Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T, Eschenfelder CC, Leonard J, Weissenborn K, Kastrup A, Haberl R; EARLY Investigators. Dengler R, et al. Lancet Neurol. 2010 Feb;9(2):159-66. doi: 10.1016/S1474-4422(09)70361-8. Epub 2010 Jan 7. Lancet Neurol. 2010. PMID: 20060783 Clinical Trial.
Circulating Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 predict Three-months Outcome after Ischemic Stroke.
Armbrust M, Worthmann H, Dengler R, Schumacher H, Lichtinghagen R, Eschenfelder CC, Endres M, Ebinger M. Armbrust M, et al. Among authors: dengler r. Exp Clin Endocrinol Diabetes. 2017 Jul;125(7):485-491. doi: 10.1055/s-0043-103965. Epub 2017 Jul 19. Exp Clin Endocrinol Diabetes. 2017. PMID: 28724170 Clinical Trial.
Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.
Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, Markus HS, Bath MW, Bath PM; Acute Antiplatelet Stroke Trialists Collaboration. Geeganage CM, et al. Among authors: dengler r. Stroke. 2012 Apr;43(4):1058-66. doi: 10.1161/STROKEAHA.111.637686. Epub 2012 Jan 26. Stroke. 2012. PMID: 22282894 Review.
Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitis.
Deb-Chatterji M, Gerdes S, Heeren M, Lambrecht J, Worthmann H, Goldbecker A, Tryc AB, Lovric S, Schulz-Schaeffer W, Brandis A, Dengler R, Weissenborn K, Haubitz M. Deb-Chatterji M, et al. Among authors: dengler r. J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):732-4. doi: 10.1136/jnnp-2012-303335. Epub 2012 Dec 15. J Neurol Neurosurg Psychiatry. 2013. PMID: 23243263
Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults.
Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, Hecker H, Schmitt R, Schiffer M, Pasedag T, Schuppner R, Tryc AB, Raab P, Hartmann H, Ding XQ, Hafer C, Menne J, Schmidt BM, Bültmann E, Haller H, Dengler R, Lanfermann H, Giesemann AM. Weissenborn K, et al. Among authors: dengler r. Neurology. 2012 Oct 2;79(14):1466-73. doi: 10.1212/WNL.0b013e31826d5f26. Epub 2012 Sep 19. Neurology. 2012. PMID: 22993286
Recombinant human erythropoietin in the treatment of acute ischemic stroke.
Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jähnig P, Herrmann M, Knauth M, Bähr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C; EPO Stroke Trial Group. Ehrenreich H, et al. Among authors: dengler r. Stroke. 2009 Dec;40(12):e647-56. doi: 10.1161/STROKEAHA.109.564872. Epub 2009 Oct 15. Stroke. 2009. PMID: 19834012 Clinical Trial.
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium. Menne J, et al. Among authors: dengler r. BMJ. 2012 Jul 19;345:e4565. doi: 10.1136/bmj.e4565. BMJ. 2012. PMID: 22815429 Free PMC article.
460 results